David C. Remy

Syntheses of 5-Trifluoromethyluracil and 5-Trifluoromethyl-2'-deoxyuridine^1,2

Charles Heidelberger, David G. Parsons, David C. Remy · Journal of Medicinal Chemistry · 1964 · 156 citations

Therapeutic Drug Monitoring, Medicinal Chemistry, Chemical Measurement +15

Nonpeptide glycoprotein IIb/IIIa inhibitors: Substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists

Nigel J. Liverton, Donna J. Armstrong, David A. Claremon et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 114 citations

Biochemistry, Medicine, Mechanism Of Action +7

Transglutaminase Inhibition by 2-[(2-Oxopropyl)thio]imidazolium Derivatives: Mechanism of Factor XIIIa Inactivation

Kurt Freund, K Doshi, Stanley L. Gaul et al. · Biochemistry · 1994 · 108 citations

Several Transglutaminases, Thrombopoiesis, Medicinal Chemistry +13

Class III Antiarrhythmic Activity in Vivo by Selective Blockade of the Slowly Activating Cardiac Delayed Rectifier Potassium Current <i>I</i>_Ks by (<i>R</i>)-2-(2,4- Trifluoromethyl)-<i>N</i>-[2-oxo-5-phenyl- 1-(2,2,2-trifluoroethyl)-2,3-dihydro- 1<i>H</i>-benzo[<i>e</i>][1,4]diazepin-3-yl]acetamide

Harold G. Selnick, Nigel J. Liverton, John J. Baldwin et al. · Journal of Medicinal Chemistry · 1997 · 94 citations · Full text

Molecular Pharmacology, Cardiac Muscle, Selective Blockade +15

<b>Syntheses of 5-Trifluoromethyluracil and 5-Trifluoromethyl-2″-Deoxyuridine</b>

Charles Heidelberger, David G. Parsons, David C. Remy · Journal of the American Chemical Society · 1962 · 76 citations

Chemical Measurement, Engineering, Chemical Analysis +12